ArticleJournal of cancer research and clinical oncology2018

TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer.

Sabine Heublein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.